Tumores Gastrintestinais

Revisão sistemática | Ultrassonografia melhorada por contraste para diagnóstico de carcinoma hepatocelular em adultos com doença hepática crônica.

6 Set, 2022 | 12:41h

Contrast‐enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease – Cochrane Library

Resumo: How accurate are contrast-enhanced ultrasound scans for detecting hepatocellular carcinoma? – Cochrane Library

 

---

Diretrizes de prática clínica para colangiocarcinoma intra-hepático.

29 Ago, 2022 | 17:46h

Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma – Liver Cancer

 

---

Diretrizes para diagnóstico e tratamento do carcinoma hepatocelular com trombose tumoral da veia porta.

29 Ago, 2022 | 17:45h

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) – Liver Cancer

 

---

M-A de rede | Eficácia de vários métodos de quimioterapia adjuvante na prevenção de metástases hepáticas de câncer colorretal potencialmente curável.

29 Ago, 2022 | 17:08h

Efficacy of various adjuvant chemotherapy methods in preventing liver metastasis from potentially curative colorectal cancer: A systematic review network meta-analysis of randomized clinical trials – Cancer Medicine

 

---

Revisão | Novos conceitos no tratamento do carcinoma hepatocelular.

29 Ago, 2022 | 16:20h

New concepts in the treatment of hepatocellular carcinoma – UEG Journal

 

---

Estudo de caso-controle | Avaliação de desfechos 1 ano após detecção de câncer gástrico precoce entre pacientes de alto risco.

29 Ago, 2022 | 13:52h

Assessment of Outcomes From 1-Year Surveillance After Detection of Early Gastric Cancer Among Patients at High Risk in Japan – JAMA Network Open

Comentário: Intensive Endoscopy Might Not Be One-and-Done for Gastric Cancer Surveillance — High-risk group had similar new lesion detection rates initially and at 15 months – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter

Among patients with a high risk of gastric cancer, 1-year surveillance was warranted even after intensive endoscopic examination using both white light and narrow-band imaging. https://t.co/3KIghTavjb

— JAMA Network Open (@JAMANetworkOpen) August 19, 2022

 

---

Estudo de braço único fase 2 | Quimioterapia neoadjuvante, excisão e observação para câncer retal não avançado.

29 Ago, 2022 | 13:42h

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results – Journal of Clinical Oncology

 

Comentário do autor no Twitter (fio – clique para saber mais)

Pleased to share our ⁦@CDNCancerTrials⁩ NEO Trial results: 79% of patients with cT1-3bN0 #rectalcancer had organ sparing therapy with 3 mo of FOLFOX/CAPOX and transanal surgery. ⁦@drcarl_vancouvr⁩ ⁦@JCO_ASCO⁩ ⁦⁦⁦@OncoAlert⁩ https://t.co/gfcywHk7Y0

— Hagen Kennecke (@HKennecke) August 18, 2022

 

---

Estudo randomizado | Efetividade da terapia com etoposídeo e cisplatina vs. irinotecano e cisplatina para pacientes com carcinoma neuroendócrino avançado do sistema digestório.

23 Ago, 2022 | 16:33h

Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial – JAMA Oncology

 

Comentário no Twitter

JCOG1213 (TOPIC NEC), the first randomized phase III trial in advanced neuroendocrine carcinoma of the digestive system, shows no significant difference in overall survival for etoposide+cisplatin versus irinotecan+cisplatin therapy https://t.co/JTELRlzTzi #GICSM pic.twitter.com/AQT8U4yd3l

— JAMA Oncology (@JAMAOnc) August 18, 2022

 

---

Análise agrupada de doença pulmonar intersticial relacionada a medicamentos e/ou pneumonite em 9 estudos de monoterapia com trastuzumabe deruxtecano.

22 Ago, 2022 | 16:34h

Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies – ESMO Open

Comentários:

Prompt recognition and treatment found effective for lung disease in patients who received new drug for advanced cancer – The Mount Sinai Health System

Trastuzumab deruxtecan-related ILD/pneumonitis characterized – medwire News

Conteúdo relacionado: Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review – Drugs

 

---

Revisão | Esôfago de Barrett.

22 Ago, 2022 | 16:06h

Barrett Esophagus: A Review – JAMA (gratuito por tempo limitado)

Revisão clínica em áudio: Barrett Esophagus – JAMA

Conteúdo relacionado: Diagnosis and Management of Barrett’s Esophagus: An Updated ACG Guideline – American Journal of Gastroenterology

 

---